Lv3
324 积分 2024-08-05 加入
Advances in immuno-based and targeted therapies in extensive-stage small cell lung cancer
19小时前
待确认
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
23天前
已完结
First-line MET tyrosine kinase inhibitors versus immunotherapy ± chemotherapy for patients with MET exon 14 skipping mutant metastatic NSCLC
28天前
已完结
Distinct molecular subtypes of KRASG12C‐mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies
29天前
已完结
Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
1个月前
已完结
Acquired resistance to PD-1 blockade in NSCLC
1个月前
已关闭
Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer
1个月前
已完结
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
1个月前
已完结
Advances and challenges in the treatment of lung cancer
1个月前
已完结
Stereotactic Ablative Radiotherapy for Oligoprogressive Cancers: Results of the Randomized Phase II STOP Trial
1个月前
已完结
皖公网安备34019202002308
